CRP and colorectal carcinoma: The critical contribution of these players and of other innate mediators, such as pentraxin-3 (PTX3) and C reactive protein (CRP), involved in early inflammatory circuits to the inflammatory milieu, have promoted studies aimed at testing their prognostic value in CRC [73,77,78,79].